Scroll To Top
Search by Speciality

The 25th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)

Hilton Hotel Vienna Austria * | Vienna, AUSTRIA
From 380 to 720 EUR
Event Preview
This event
is Finished
Title: The 25th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)
Specialty: Obstetrics and Gynecology
Dates: From Nov, 30, 2017 to Dec, 2, 2017
Location: Vienna, AUSTRIA
Type: Congress
Registration Cost: From 380 to 720 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for VIENNA, Austria.
General Info
Event Venue:

Hilton Hotel Vienna Austria *

VIENNA, AUSTRIA Visit the Venue to read more


The 25th World Congress on Controversies in Obstetrics, Gynecology & Infertility, November 30 – December 2, 2017 will be submitted for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME). The EACCME is an institution of the European Union of Medical Specialists (UEMS):

The CME accreditation is valid for the main congress program only and does not cover the industry-sponsored symposia.

ISO 9001 CertificationThis quality certification requires all participants to fill in a scientific questionnaire to evaluate the overall quality of the event.

CME for USA participants
UEMS/EACCME CME credit recognition
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Under the terms of this agreement, the AMA will convert CME credit certified by the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, to AMA PRA Category 1 Credit™.
Physicians (MDs, DOs or equivalent international degree) may have their EACCME credit converted to AMA PRA Category 1 Credit™ by applying to the AMA.

Educational needs and expected outcomes

  • Assess and appraise controversial issues based on the latest findings by leading scientists in the field of obstetrics, gynecology and infertility
  • Evaluate best practices in obstetrics, gynecology and infertility
  • Discuss new scientific knowledge and recent research findings
  • Recognize opportunities for scientific collaborations
  • Integrate the most up-to-date information in clinical and research activities
  • Evaluate the most important aspects of diagnosis and treatment in obstetrics, gynecology and infertility

Presentations, discussions and debates will focus on the latest developments in obstetrics, gynecology and infertility.

Disclosure of Conflicts of Interest (COI)All declarations of potential or actual conflicts of interest, whether due to a financial or other relationship, must be provided to the EACCME® upon submission of the application. Declarations must include whether any fee, honorarium or arrangement for re-imbursement of expenses in relation to the event has been provided.

Industry support disclosure
We confirm that all funding provided is free of any attempt to influence the program, individual sessions, subjects for discussion, content or choice of faculty members conflicts of interest. Support of the congress is kept in strict accordance with CME accreditation criteria.

Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Transportation Guide:
By Car

From Vienna International Airport drive west along the A4 towards Vienna. Take the exit Zentrum-Erdberg and continue on the access road Schuettelstrasse. Go straight ahead for about 2.5 km until you arrive at Aspernbruecke. Drive over the bridge and turn left onto Stubenring - Parkring (passing the Stadtpark on the left). You will see "Huebners Kursalon" at the end of the Stadtpark. Turn left onto Johannesgasse and drive for approximately 200 m to the 2nd traffic light. Turn left onto Am Heumarkt and drive 150m straight ahead, the garage entrance of Hilton Vienna is located on the right hand side.

From A2 Südautobahn (Graz)

Drive to the city border until you are on highway A2 Südautobahn, which flows into the A23 Südosttangente. Remain on the A23 and take the exit Landstrasser Gürtel. Take the right-hand lane and drive 200m downhill to the second traffic light crossing. After the lights, turn into Landstrasse Hauptstrasse. Drive straight ahead to the end of the road and turn into the Invalidenstrasse. Continue straight ahead for about 100 m and then turn right into Grosse Ungarbrücke. After 10m, turn right again and in 15m you will see the garage entrance of the Hilton Vienna hotel to your right.

By Public Transportation:

The Hilton Vienna hotel has a direct airport connection via the city airport train (CAT), opposite the hotel. You can also take the 'Schnellbahn' heading for Floridsdorf. Exit the station at Wien Mitte, which is directly next to the Hilton Vienna hotel.

By public transportation from Hauptbahnhof, take the U1 line in the direction of Leopoldau to Stephansplatz. Then change to the U3 line, heading in the direction of Simmering, to Landstrasse. Exit the station at Wien Mitte, which is directly next to the Hilton Vienna hotel.
Event Overview
Welcome message:

Welcome from Chairs

Dear Colleagues,

We are pleased to announce that the 25th World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI) will be held       November 30 – December 2, 2017 in Vienna, Austria.

The COGI Congress will continue to provide an innovative and comprehensive overview of the latest research developments in the field, primarily in the areas of IVF, FMM, Family Planning, Menopause and Gyne-Oncology. Many distinguished gynecologists and scientists will join the faculty and will present their experiences and research in the form of debates, discussions and plenary lectures.

The congress will again provide a forum to effectively debate unresolved clinical and therapeutic dilemmas.

We look forward to welcoming you to the vibrant and beautiful city of Vienna.


Thematology / Presented Topics:

Preliminary Topics


  • Technical surgical consideration
  • Results of surgery
  • Perinatal pitfall and results
  • Artificial Uterus – state of the art


  • Ovarian stimulation – lessons from over 30 years of IVF
  • Innovative stimulation
  • How to assess the polycystic ovary: An ultrasound and AMH update
  • Screening and management of hypothyroidism


  • Evidence base fibroids removal prior to IVF
  • When to use hysteroscopy and when to use laparoscopy for removal
  • SPRMs mechanism of action on fibroids
  • Medical treatment of fibroids in infertile women


  • Medical protection of gonadal damage
  • Ovarian tissue transplantation techniques and results
  • Ovarian tissue freezing- the lab perspectives
  • The potential of spermatogonial stem cells as target for fertility preservation in boys


  • Debate: Mosaicism- some PGS labs report mosaicism and others not. Why? Should we transfer mosaic embryos? What are the legal risks?
  • Debate: PGS
    All embryos should be tested
    No embryo should be tested


  • role of hysteroscopy before IVF. Diagnosis and treatment of Chronic Endometritis
  • Role of Hysteroscopy in proximal tubal occlusions
  • Medical and Surgical therapy for adenomyosis
  • Uterine adenomyosis: Hysteroscopic and laparoscopic approaches


  • Diagnosis of Endometriosis
  • Deep endometriosis: back to less aggressive surgery
  • Complications of deep endometriosis surgery: How to avoid them
  • Laparoscopic management of the ovarian endometrioma: Why and how?


  • Oocytes quality deterioration with age: Chromosomes or else?
  • The saga of older age and poor responders: Have we made any progress?
  • Androgens: Do they make any difference?
  • Evidence based Luteal support: Are poor responders different?


  • The window of implantation: What do we now?
  • AUGMENT by OvaScience: What is the evidence? what to practitioners need to know about what is being injected
  • Endometrial scratch any solid proofs?


  • IVF in the medically complicated patient
  • Periconceptional medicine and the obstetrician
  • Pre-eclampsia: A periconceptional disease


  • In vitro activation of dormant follicles
  • Mitochondrial diseases: technical issues and future therapy
  • improve the sperm selection
  • Quality control in ART
  • Mitochondrial DNA (mtDNA) as biomarker of preimplantation embryo viability


  • Blastocoel analysis for PGS and the potential clinical value of mitochondrial screening assays
  • PGS on culture media
  • Mitochondrial DNA (mtDNA) as biomarker of preimplantation embryo viability


  • Debate: Evidence based benefit or simply closed system?
  • Debate: Time lapse: What did we learn so far? Does universal algorithms work?
  • Embryo development on day 3-4 what can be learned
  • Debate: Metabolic needs of human embryos. Nurturing and improving quality of oocytes in the IVF laboratory
  • Towards the best culture system



  • Sparing Options in Gynecologic Oncology surgery
  • Fertility-sparing surgery in early-stage cervical cancer
  • Fertility-Sparing Management in Young Endometrial Cancer Patients
  • Assisted reproductive techniques after fertility-sparing treatments
  • Fertility-sparing treatment of endometrial cancer


  • The adoption of HPV vaccines in the world and the axes of assessment of vaccine safety
  • Vaccine confidence and vaccine hesitancy
  • The promises of the HPV vaccines
  • The role of the gynecologists in HPV vaccination


  • The role of lymphadenectomy in the surgical treatment of endometrial cancer
  • Adjuvant therapy of endometrial cancer
  • Lynch syndrome in endometrial cancer patients


  • Antiangiogenic treatment in ovarian cancer
  • PARP-inhibition in ovarian cancer patients


  • HRT – WHI authors claim about wrong data interpretation
  • Debates: HRT – Have the risks been overestimated? Will it rebound to pre-WHI era?
  • Debate: Vaginal application of sex steroids: The future in women’s health? What are the limitations?
  • HRT – Oral vs. Transdermal application
  • Prevention of peri-menopausal obesity by diet and life style intervention
  • Fat accumulation around the menopause – the implications
  • Managing obesity: the place of bariatric surgery
  • Exercising in menopause
  • Medical treatment of endometriosis in the perimenopause


  • Progesterone (or hormones) and breast cancer
  • Chemoprevention and prophylactic surgery for breast cancer


  • Neovagina using autologous cultured vagina tissue
  • Vulvovaginoplasty
  • Creation of a neovagina by Davydov’s laparoscopic modified technique in patients with Rokitansky syndrome


  • Which estrogen for contraceptive pills
  • WHO guidelines for contraception – how to improve them?
  • Contraceptives and thrombotic risks
  • Contraceptive options for adolescent and the peri-menopausl
  • OC’s are associated with depression?


  • Debate: HRT – Cardiovascular risk or prevention?
  • HRT – How to prevent and/or treat (uterine) bleeding problems
    Can we prevent Alzheimer
  • Ovarian tissue re-implantation: The HRT of the  future


  • Breast cancer and bone health


  • Shoulder dystocia and Erb’s palsy: Can we do better?
  • Are the criteria for the association between perinatal events and brain damage valid?
  • Already brain damaged upon admission: can we diagnose?
  • Planned home birth: A challenge of Perinatal Medicine


  • Amniotic fluid emboli: Radical change in outlook
  • Intrapartum emergencies in twin birth
  • Debate: Selecting the first line drug for prevention of PPH – Oxytocin / Carbetocin


  • Is pessary useful in prevention of preterm labor in singleton and twins
  • Steroids for late preterm birth
  • The long-term cardiovascular consequences of SGA
  • Should Progesterone still be used for PTL after the OPPTIMUM negative study?


  • Debate: Is there a minimal advised period before conception after C-Section?
    Proposition: Wait 6 or 12 months before pregnancy
    Opposition: No time limit before new pregnancy after CS
  • Cesarean scar defect – Why some women develop Niche? What are the risks?
  • Surgical management of cesarean scar defect? Laparoscopy or Hysteroscopy
  • Debate: Induction of labour decreases the CS rate
  • Does episiotomy decrease the third and fourth degree tear rate?


  • Fetoscopic Surgery for Congenital Birth Defects: From Bench to Bedside
  • Diagnosis and treatment of twin-to-twin transfusion syndrome
  • Treatment of diaphragmatic hernia
  • Fetal cardiac interventions: State of the art


  • Zika – Update
  • Strategies for GBS screening, prevention and treatment in the perinatal period (new consensus guidelines)
  • Is there a cure for perinatal HIV-infected children?
  • Bacterial and viral infections during pregnancy increase the risk of autism and schizophrenia in offspring
  • Overview of Viral infection during pregnancy
  • Infectious exposure during pregnancy and delivery and cerebral palsy


  • Debate – Steroids for late preterm birth
  • Late effects of CS

Registration Up to Date Register Now
General Info:

Register for the COGI experience



Registration Cost


Early Registration

Late Registration From: 2017-09-28 To: 2017-11-28
On site Registration
Congress Program and Abstract Book
Physicians and Scientists
Nurses, Students, Residents**

**Fellows, Allied Health Professionals, Consumer Advocates.

**For your convenience, the scientific program of the congress will be available online in the COGI web application. Participants can purchase a printed congress program and abstract book for EUR 15.00 per book.
The registration fee includes: scientific updates, admission to all scientific sessions and the exhibition, admission to opening networking reception, participation in the young scientist competition, participation in breakthrough and innovation competition, the congress e-program, access to COGI social networks, coffee and lunch breaks, a certificate of attendance, and access to all relevant meeting information.

Group Registrations:

More Info:

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

MCI is the only official mandated housing bureau for the COGI Congress. The COGI Congress cannot validate hotel reservations via sources other than those presented by MCI. With careful research and dedicated negotiations, MCI works on your behalf to provide hotel room blocks of a high-quality standard at a discounted rate. For the best customer service and guaranteed hotel rooms, attendees and exhibitors should make their reservation through the official housing bureau offer provided in this registration system. It is important to be aware that you may be contacted by phone, fax, or email by third party companies that act as travel agencies, wholesalers or destination management companies to solicit you with aggressive or deceptive tactics for room reservations. Room poachers and pirates may also misrepresent themselves as the official congress housing bureau and may illegally use the congress name or logo. If you are contacted by someone asking if you need a room during the COGI Congress or if they represent themselves as the official housing bureau for the COGI Congress, please obtain as much information as you can, such as the name of the company, the person calling and their telephone number, and then please contact MCI Geneva at +41 22 33 99 586;
Scientific Content Up to Date
Scientific Program:
Submission Info
Abstracts may be submitted for the following topics:
2. Gynecology
3. HPV
4. Urogynecology
5. Oncology
6. Fetomaternal Medicine
7. Other
An abstract cannot be accepted if the conflict of interest disclosure is not signed.
Abstracts must contain data and meet international ethical standards.
Abbreviations should be defined.
Abstract submission deadline 2017-08-31
Editorial Guidelines for Abstract Submission
Abstracts should be submitted in English and contain no more than 3,600 characters, including titles, graphs and non-visible characters, such as spaces and line breaks.
Please write concisely and clearly and follow this structure:
Problem statement: Why do we care about the problem?
Methods: What did you actually do to get your results?
Results: What did you learn/invent/create?
Conclusion: What are the implications of your findings?
Please ensure that your abstract does not contain spelling, grammar or scientific mistakes, as it will be reproduced exactly as submitted. No proofreading will be done. Linguistic accuracy is the responsibility of the submitter.
Images/graphs/tables can be uploaded according to the following criteria:

  • Width (in pixels): min 50 / max 750
  • Height (in pixels): min 50 / max 750
  • Size (in KB): min 20/ max 1,000
  • Resolution (dpi): min 96 / max 300. The standard display size for images is 96 dpi.
  • Format: JPG, PNG or GIF
You may improve the quality of your image for publication by increasing the number of dpi as well as the height and width of the image (in pixels).
If you wish to modify your image, you may use the programme Paint.Net (free software).
Abstract submissions that do not meet the above noted guidelines may be rejected without review.
The Organizing Committee may request additional information about abstracts and rejected abstracts.
Editorial Guidelines for Presented Content:
Authors should select their presentation preference. Final decision on the presentation type will be made by the Organizing Committee.
Oral presentation: The abstract is selected for oral presentation at any of the free communication sessions. --> Note: The number of oral presentations is limited. Abstracts with preference for oral presentation will be selected by the Organizing Committee.
Poster presentation: The abstract is selected for presentation in a poster format. Posters will be on display throughout the congress.
Book only: The submitter chooses not to present the abstract in oral or poster format. The abstract will only appear in the abstract book.
Scientific Awards

The Organizing Committee invites young physicians, scientists and researchers to submit their abstracts and join the competition for the Young Scientist Award. 

The winner(s) will receive a cash prize.

It’s very simple.
1. Submit your abstract via the congress website no later than August 31, 2017.
2. Register for the congress and pay the registration fee. If you are one of the winners, you will be reimbursed as per above.
3. Remember to include your date of birth during the registration process.

Great! So what are the guidelines for submitting?

  • Submitters must be born in or after 1983 at the time of submission. 
  • Submitters must be the first author of the abstract.
  • Submitters must register and pay registration fees by September 28, 2017.
  • Attendance at the congress by the winner is mandatory in order to receive and collect the award.
  • Winners who cancel for any reason will not be entitled to collect their award.
  • Only the winners can claim their award on site at the congress.

Please note that abstracts sent by email or fax will be rejected automatically.

The Organizing Committee reserves the right to change the conditions at any time without notice.

Sponsors Exhibitors
General Info

For further information, please contact the Congress Secretariat:

Tel. +972 72 279 0306
Fax. +972 3 725 6266

It is the responsibility of the supporters and exhibitors to comply with all applicable legislation, regulation and industry codes; in particular local guidelines; the European Federation of Pharmaceuticals Industries and Associations (EFPIA); International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Eucomed.

Exhibition Consensus
Ilana Rabinoff-Sofer Tel aviv, Israel
5 Druyanov Street
Organising Agency
Official Event Webpage
Event map
Revelant Events